Orthofix Medical Q3 2023 Adj. EPS $0.07 Beats $(0.21) Estimate, Revenue $184M Misses $185.910M Estimate
Portfolio Pulse from Benzinga Newsdesk
Orthofix Medical reported Q3 2023 adjusted EPS of $0.07, beating the estimate of $(0.21). However, the company's revenue of $184M fell short of the estimated $185.910M.
November 08, 2023 | 9:27 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Orthofix Medical's Q3 2023 earnings beat estimates but revenue missed, which could lead to mixed market reactions.
Orthofix Medical's earnings beat estimates, which is a positive signal for investors and could drive the stock price up. However, the company's revenue missed estimates, which could negatively impact the stock price. The net effect on the stock price is uncertain, hence the neutral score.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100